45 results on '"Serrano-Macia, Marina"'
Search Results
2. The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis
3. SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer
4. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
5. Neddylation of phosphoenolpyruvate carboxykinase 1 controls glucose metabolism
6. Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting
7. Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation
8. Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly
9. miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease
10. FRI-153 High prevalence of steatotic liver disease and systemic inflammation in hereditary fructose intolerance (HFI) patients independent of age, BMI and the presence of metabolic syndrome
11. Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis
12. Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury
13. Pediatric liver cancer: Hepatoblastoma and Neddylation post-translational modification
14. Silencing CNNM4 in cholangiocarcinoma inhibits tumoral progression by means of non-canonical ferroptosis
15. Metabolic rewiring by increased mitochondrial respiration drives immunosuppression in liver cancer
16. Neddylation inhibition recovers drug-induced liver injury through the stabilization of Tamm41
17. Magnesium modulation by CNNM4 silencing in DIAMOND mice via GalNAc-siRNA therapy: a new and effective therapeutic approach against MAFLD
18. MAP17 promotes metastasis in hepatocellular carcinoma by modulating the epithelial-mesenchymal-amoeboid transition
19. Targeting liver glutaminase 1 modulates hepatic ammonia in experimental Non-Alcoholic Steatohepatitis
20. Magnesium accumulation by CNNM4 GalNAc-siRNA mediated silencing reduces cholestasis-associated liver fibrosis
21. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumour-stroma crosstalk in experimental models
22. Targeting cyclin M4 as a new therapeutical approach to treat alcoholic liver disease
23. FRI-466-YI Implications and therapeutic potential of neddylation for pediatric liver cancer: hepatoblastoma
24. WED-113 Histological, molecular, and neuromotor alterations of the liverbrain axis in an aged model of experimental cirrhosis
25. SAT-244 - Silencing CNNM4 in cholangiocarcinoma inhibits tumoral progression by means of non-canonical ferroptosis
26. SAT-247 - Pediatric liver cancer: Hepatoblastoma and Neddylation post-translational modification
27. SAT-221 - Metabolic rewiring by increased mitochondrial respiration drives immunosuppression in liver cancer
28. FRI-399 - Neddylation inhibition recovers drug-induced liver injury through the stabilization of Tamm41
29. NEDD8 specific protease 1 (NEDP1) as a tumor suppressor in hepatocellular carcinoma
30. MCJ deficiency results in gut barrier dysfunction and macrophage-elicited inflammation following ethanol consumption, facilitating alcoholic endotoxemia
31. Novel therapy with anti-miR-873-5p at late stages of acetaminophen overdose
32. miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease
33. miR-873-5p targets mitochondrialGNMT-Complex II interface contributing tonon-alcoholic fatty liver disease
34. The Balance between Mono- and NEDD8-Chains Controlled by NEDP1 upon DNA Damage Is a Regulatory Module of the HSP70 ATPase Activity
35. FRI-353-Metabolic implications of methionine adenosyltransferase 1A depletion during fasting
36. FRI-343-NEDDylation inhibition as a new potential therapy of non-alcoholic fatty liver disease
37. FRI-294-Mitochondrial GNMT-complex II is recovered by miR-873-5p targeting in NAFLD
38. PS-034-MCJ: A therapeutic target in hepatic ischemia and reperfusion injury
39. THU-477-Sumoylation/acetylation drives forward oncogenic role of LKB1 in Liver
40. FRI-094-Targeting NEDDylation protects liver from acute drug-induced damage
41. The NEDD8 cycle controlled by NEDP1 upon DNA damage is a regulatory module of the HSP70 ATPase activity
42. SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer
43. FRI502 - NEDD8 specific protease 1 (NEDP1) as a tumor suppressor in hepatocellular carcinoma.
44. THU185 - Novel therapy with anti-miR-873-5p at late stages of acetaminophen overdose.
45. AS110 - MCJ deficiency results in gut barrier dysfunction and macrophage-elicited inflammation following ethanol consumption, facilitating alcoholic endotoxemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.